U.S. Food and Drug Administration (FDA)
Is DSIP (delta sleep-inducing peptide) legal in United States?
Not approvedNo FDA approval; advisers reviewed emideltide (DSIP) in July 2026 and, per a law-firm report, did not recommend it
Not approved as a medicine here.
DSIP is called emideltide on FDA's lists and is not approved for any use. FDA's Category 2 page lists it among withdrawn nominations. The Pharmacy Compounding Advisory Committee reviewed emideltide for opioid withdrawal, chronic insomnia and narcolepsy on 24 July 2026 and, according to a law-firm report, voted against recommending it (6 yes, 7 no, 1 abstention). It is not on the 503A bulks list.
Last verified 2026-09-29 · how we verify
DSIP (delta sleep-inducing peptide) elsewhere
Sources (3)
- 01Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (Category 2 and withdrawn nominations)U.S. Food and Drug Administration · 2026-04-22 · accessed 2026-09-29
- 02July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory CommitteeU.S. Food and Drug Administration · 2026-08-06 · accessed 2026-09-29
- 03Bulk list bound? PCAC backs majority of peptides in two-day public meetingMcDermott Will & Schulte · 2026-07-27 · accessed 2026-09-29